October 2006

Charles River Laboratories Acquires U.S. Phase I Unit

Tuesday, October 31, 2006

Wilmington, Mass.-based Charles River Laboratories has stepped up its clinical research presence with the purchase of Northwest Kinetics, a 150-bed unit early phase clinical pharmacology unit in Tacoma, Wash. The deal is worth $29.5 million and may signal that Charles River has interest in expanding its clinical development business, after selling off much of that to Kendle last year. Watch for the in depth story in an upcoming issue of our CWWeekly newsletter.

[Read More]

Phase Forward reports 26% increase in third quarter revenue

Monday, October 30, 2006

Waltham, Mass.-based Phase Forward reported a 26% increase in third quarter 2006 revenues compared with the same period in 2005. The company reported third quarter revenues of $28 million, up from $22.2 million last year. For the fourth quarter of 2006, the company reported it expects revenues to be between $29.2 and $30.0 million. Income from operations was $4 million, showing a margin of 14.2% and an increase of 66% from the prior year period. The company reported expected revenues for the entire 2006 fiscal year to be between $105.6 and $106.4 million. On non-GAAP basis, the company expects EPS between $0.37 and $0.38.

[Read More]

Phase I Doesn’t Faze Them

Wednesday, October 25, 2006

It was interesting to see Waltham, Mass.-based Parexel, a global contract research organization (CRO), remaining unfazed in the hot phase I clinical research market. Earlier this month, Parexel agreed to acquire California Clinical Trials and Behavioral and Medical Research for $65 million. A key part of the deal is a 51-bed phase I unit that would boost Parexel’s presence in the phase I market.

[Read More]

Smaller EMR Companies Could Push Integration

Tuesday, October 17, 2006

The use of electronic medical records (EMR) technology to enhance the conduct and efficiency of clinical trials has been highly touted of late. The ability to utilize hospital medical records in patient recruitment is seen as a promising solution to costly subject recruitment delays. Companies operating in the EMR space are looking for ways to integrate their systems to work togther with established eClinical infrasture. Aside from a few of the global IT giants such as Siemen AG and Oracle Clinical, GE Healthcare and McKesson, some of the smaller players in EMR may be the ones to watch out for. Being smart, quick and nimble has a big advantage in the IT idustry.

[Read More]